- Advanced drug delivery technologies for challenging oral compounds to address poor solubility, low bioavailability, high doses, high variability, and poor tolerability
- Differentiating features of next generation gastro-retentive and chronotherapeutic technologies and their utility in untapping the therapeutic potential of a wide range of molecules
- Case studies of challenging drugs using these technologies to improve the drug’s efficacy, adverse effects, and compliance.
Pavan Handa, Senior Vice President, Specialty Portfolio Management, Amneal Pharmaceuticals
Dipen Desai, Vice President Formulation & Analytical, Amneal Pharmaceuticals
